Trial reportSurgical endoscopy2025
Fluorescence-guided sleeve gastrectomy and gastric bypass: first-in-human trial using novel gastric calibration tube.
Trial report in Surgical endoscopy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT05486325 (Pilot Study of the Endolumik Gastric Calibration Tube for Bariatric Surgery), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Pilot Study of the Endolumik Gastric Calibration Tube for Bariatric Surgery
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionFluorescence-guided surgery employs a near-infrared emitting dye or light source to enhance intraoperative visualization. This study reports the first-in-human application of the Endolumik fluorescence-guided calibration tube (EGCT) during laparoscopic sleeve gastrectomy (SG) and gastric bypass (GB).
methodsUnder IRB approval (NCT05486325), two surgeons performed 21 laparoscopic SG and 10 GB procedures using EGCT. Evacuation of gastric contents, gastric sleeve/pouch calibration, and leak testing were performed. Surgical and anesthesia providers completed surveys evaluating their EGCT experience.
resultsNo device-related adverse events occurred. EGCT was used by 10/5 unique surgical team members during SG/GB, respectively, and by 20/5 anesthesia providers. All surgical team members rated device experience as good or very good compared to the standard bougie. Visualization during gastric sleeve construction was rated as good or very good, and very good for gastric pouch construction. All surgical members reported confidence in the device enabling consistent gastric sleeve or pouch sizing. EGCT increased surgeon confidence level for device introduction during GB. Among anesthesia providers, 84% rated their experience during SG with the device as good or very good, including 89.5% of CRNAs. Additionally, 75%/90% of SG/GB clinicians believed the device reduced the likelihood of adverse events compared to standard devices. The average likelihood to recommend the EGCT was 9 out of 10 among surgeons.
conclusionEGCT improved visualization during gastric sleeve and pouch construction and increased confidence during device introduction for GB; surgeons would recommend the device to colleagues. Further research is needed to assess the impact on clinical outcomes.
Indexed as
Identifiers
40897881What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.